Technical Analysis for PRME - Prime Medicine, Inc.

Grade Last Price % Change Price Change
F 17.25 1.65% 0.28
PRME closed down 2.75 percent on Monday, January 30, 2023, on 35 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 1.65%
20 DMA Support Bullish 1.65%
20 DMA Support Bullish -1.15%
Crossed Above 50 DMA Bullish -1.15%
Up 3 Days in a Row Strength -1.15%
Up 4 Days in a Row Strength -1.15%
Up 5 Days in a Row Strength -1.15%
Crossed Above 20 DMA Bullish 0.17%
Up 3 Days in a Row Strength 0.17%
Up 4 Days in a Row Strength 0.17%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
50 DMA Resistance about 2 hours ago
60 Minute Opening Range Breakout about 2 hours ago
Rose Above Previous Day's High about 2 hours ago
Rose Above Upper Bollinger Band about 2 hours ago
Rose Above 50 DMA about 2 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Prime Medicine is a biotechnology company committed to delivering a new class of differentiated, one-time, curative genetic therapies to address the widest spectrum of diseases. The company is deploying Prime Editing technology, a versatile, precise, efficient and broad gene editing technology, which is designed to make only the right edit at the right position within a gene. With the theoretical potential to repair approximately 90 percent of known disease-causing genetic mutations across many organs and cell types, medicines based on Prime Editing, if approved, could offer a one-time curative genetic therapeutic option to a broad set of patients.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Disease Emerging Technologies Molecular Biology Medical Genetics Genetic Engineering Gene Editing Technology

Is PRME a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 21.7301
52 Week Low 14.52
Average Volume 205,245
200-Day Moving Average 0.00
50-Day Moving Average 17.38
20-Day Moving Average 16.85
10-Day Moving Average 16.65
Average True Range 1.04
RSI 50.00
ADX 11.67
+DI 17.91
-DI 12.71
Chandelier Exit (Long, 3 ATRs) 17.01
Chandelier Exit (Short, 3 ATRs) 18.54
Upper Bollinger Bands 18.21
Lower Bollinger Band 15.49
Percent B (%b) 0.54
BandWidth 16.13
MACD Line -0.11
MACD Signal Line -0.22
MACD Histogram 0.1136
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.89
Resistance 3 (R3) 17.94 17.68 17.74
Resistance 2 (R2) 17.68 17.45 17.66 17.69
Resistance 1 (R1) 17.33 17.31 17.20 17.28 17.63
Pivot Point 17.07 17.07 17.01 17.05 17.07
Support 1 (S1) 16.71 16.84 16.59 16.66 16.31
Support 2 (S2) 16.46 16.69 16.43 16.25
Support 3 (S3) 16.10 16.46 16.20
Support 4 (S4) 16.05